NeurogeneNGNE 
$40.27-5.82%24h
-5.82%24h
Global rank11231
Market cap$516.41M
Change 7d13.44%
YTD Performance107.79%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Neurogene (NGNE)
As of November 2024, Neurogene has a market cap of $516.41M. This makes Neurogene the world's 11231th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Neurogene from 2014 to 2024
-
Value:-
Market cap history of Neurogene from 2014 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $382.53M | 53.92% |
| 2023 | $248.52M | 90.37% |
| 2022 | $130.55M | -89.44% |
| 2021 | $1.24B | -65.82% |
| 2020 | $3.62B | 14.45% |
| 2019 | $3.16B | 470.37% |
| 2018 | $553.98M | -81.63% |
| 2017 | $3.02B | -28.77% |
| 2016 | $4.23B | 32.29% |
| 2015 | $3.20B | 66.40% |
| 2014 | $1.92B | - |
NGNE Market Cap Today is $516.41M -5.82% - 4 Nov 2024
View largest stocks by market cap 
